First report of molecular detection of fluoroquinolone resistance-associated gyrA mutations in multidrug-resistant clinical Mycobacterium tuberculosis isolates in Kuwait

BACKGROUND: Nearly 5% of all Mycobacterium tuberculosis strains worldwide are resistant at least to rifampicin and isoniazid (multidrug-resistant tuberculosis, MDR-TB). Inclusion of a fluoroquinolone and an injectable agent (kanamycin, amikacin or capreomycin) in multidrug therapy is crucial for pro...

Full description

Saved in:

Bibliographic Details
Main Authors:	Al-Mutairi, Noura M, Ahmad, Suhail, Mokaddas, Eiman
Format:	Artigo
Language:	Inglês
Published:	BioMed Central 2011
Subjects:	Short Report
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3095995/ https://ncbi.nlm.nih.gov/pubmed/21492420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-4-123
Tags:	Add Tag No Tags, Be the first to tag this record!

First report of molecular detection of fluoroquinolone resistance-associated gyrA mutations in multidrug-resistant clinical Mycobacterium tuberculosis isolates in Kuwait

Similar Items